These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39266922)

  • 1. Transduced Olfactory Mucosa Cells Expressing Nerve Growth Factor for the Therapy of Experimental Spinal Cord Cysts.
    Stepanova OV; Fursa GA; Andretsova SS; Karsuntseva EK; Shishkina VS; Chadin AV; Voronova AD; Semkina AS; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2024 Aug; 177(4):552-558. PubMed ID: 39266922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the Therapeutic Efficiency of Transduced Olfactory Ensheathing Cells in Spinal Cord Cysts.
    Stepanova OV; Voronova AD; Sosnovtseva AO; Stepanenko AA; Chadin AV; Karsuntseva EK; Fursa GA; Valikhov MP; Semkina AS; Vorobyev PO; Reshetov IV; Chekhonin VP
    Stem Cells Dev; 2022 Jan; 31(1-2):9-17. PubMed ID: 34847755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of a New Gene-Cell Construct Based on the Olfactory Mucosa Escheating Cells Transduced with an Adenoviral Vector Encoding Mature BDNF in the Therapy of Spinal Cord Cysts.
    Karsuntseva EK; Fursa GA; Sosnovtseva AO; Voronova AD; Chadin AV; Semkina AS; Stepanova OV; Chekhonin VP
    Bull Exp Biol Med; 2022 Mar; 172(5):617-621. PubMed ID: 35352253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obtaining a New Gene-Cell Construct Based on Transduced Olfactory Ensheathing Cells for the Treatment of Spinal Cord Injuries.
    Voronova AD; Sosnovtseva AO; Stepanova OV; Chadin AV; Karsuntseva EK; Fursa GA; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2022 Aug; 173(4):529-533. PubMed ID: 36058977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and Migration of Rat Olfactory Ensheathing Cells after Transplantation into Posttraumatic Cysts in the Spinal Cord.
    Voronova AD; Valikhov MP; Stepanova OV; Mel'nikov PA; Chadin AV; Sidoruk KN; Semkina AS; Abakumov MA; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2018 Nov; 166(1):118-123. PubMed ID: 30417294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Efficiency of Transplantation of Rat and Human Olfactory Ensheathing Cells in Posttraumatic Cysts of the Spinal Cord.
    Voronova АD; Stepanova OV; Valikhov MP; Chadin AV; Semkina АS; Abakumov MA; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2019 Aug; 167(4):536-540. PubMed ID: 31502130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine olfactory ensheathing cells from the olfactory mucosa can be engineered to produce active chondroitinase ABC.
    Carwardine D; Wong LF; Fawcett JW; Muir EM; Granger N
    J Neurol Sci; 2016 Aug; 367():311-8. PubMed ID: 27423610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Preparation of Human Olfactory Ensheathing Cells in the Therapy of Post-Traumatic Cysts of the Spinal Cord.
    Voronova AD; Stepanova OV; Valikhov MP; Chadin AV; Semkina AS; Karsuntseva EK; Fursa GA; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2020 Aug; 169(4):539-543. PubMed ID: 32910386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Transplantation of Olfactory Ensheathing Cells on the Size of Posttraumatic Spinal Cord Cysts.
    Voronova AD; Stepanova OV; Chadin AV; Fursa GA; Karsuntseva EK; Valikhov MP; Semkina АS; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2021 May; 171(1):122-126. PubMed ID: 34046791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Rat Olfactory Ensheathing Cells and Their Use in the Therapy of Posttraumatic Cysts of the Spinal Cord.
    Stepanova OV; Voronova АD; Chadin AV; Valikhov MP; Abakumov MA; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2018 May; 165(1):132-135. PubMed ID: 29796806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of therapeutic effects of olfactory ensheathing cells derived from olfactory mucosa or olfactory bulb on spinal cord injury mouse models].
    Wang L; Yang P; Liang X; Ma L; Wei J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Apr; 30(4):379-83. PubMed ID: 24721406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.
    Hamilton MM; Byrnes GA; Gall JG; Brough DE; King CR; Wei LL
    Mol Vis; 2008; 14():2535-46. PubMed ID: 19122827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of a 'stealth' adenoviral vector for targeted gene delivery to adult mammalian neurones.
    Sims K; Ahmed Z; Read ML; Cooper-Charles L; Gonzalez AM; Fisher KD; Berry M; Seymour LW; Logan A
    J Gene Med; 2009 Apr; 11(4):335-44. PubMed ID: 19248141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of Human Olfactory Ensheathing Cells for the Therapy of Spinal Cord Injuries.
    Voronova АD; Stepanova OV; Valikhov MP; Chadin AV; Dvornikov АS; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2018 Mar; 164(4):523-527. PubMed ID: 29504110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of Human Olfactory Ensheathing Cell Transplantation into Spinal Cysts to Improve Mobility of the Hind Limbs.
    Stepanova OV; Voronova AD; Chadin AV; Valikhov MP; Semkina AS; Karsuntseva EK; Chekhonin IV; Shishkina VS; Reshetov IV; Chekhonin VP
    Stem Cells Dev; 2019 Sep; 28(18):1253-1263. PubMed ID: 31310179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival, integration, and axon growth support of glia transplanted into the chronically contused spinal cord.
    Barakat DJ; Gaglani SM; Neravetla SR; Sanchez AR; Andrade CM; Pressman Y; Puzis R; Garg MS; Bunge MB; Pearse DD
    Cell Transplant; 2005; 14(4):225-40. PubMed ID: 15929557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord.
    Ruitenberg MJ; Plant GW; Hamers FP; Wortel J; Blits B; Dijkhuizen PA; Gispen WH; Boer GJ; Verhaagen J
    J Neurosci; 2003 Aug; 23(18):7045-58. PubMed ID: 12904465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotrophin-3 Enhances the Effectiveness of Cell Therapy in Chronic Spinal Cord Injuries.
    Stepanova OV; Voronova AD; Chadin AV; Fursa GA; Karsuntseva EK; Valikhov MP; Semkina AS; Reshetov IV; Chekhonin VP
    Bull Exp Biol Med; 2022 May; 173(1):114-118. PubMed ID: 35622252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of altering titer, serotype, and promoter in recombinant adenoassociate virus gene therapy expression of spinal cord neurons and astrocytes.
    Harrop JS; Poulsen DJ; Xiao W; Freese A; During MJ
    Spine (Phila Pa 1976); 2004 Dec; 29(24):2787-92. PubMed ID: 15599280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrate.
    Rooney GE; Moran C; McMahon SS; Ritter T; Maenz M; Flügel A; Dockery P; O'Brien T; Howard L; Windebank AJ; Barry FP
    Tissue Eng Part A; 2008 May; 14(5):681-90. PubMed ID: 18402551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.